Texas Children’s Provides New Breakthrough Treatment for Patient with Rare Neurological Disorder
Texas Children's is pleased to announce that a three-year-old girl has been successfully treated with the first-ever FDA-approved gene therapy treatment for AADC deficiency. https://mma.prnewswire.com/media/2752751/Texas_Children_s_Hospital.jpg Texas Children's has performed the first-ever FDA-approved gene therapy treatment for AADC deficiency. Aromatic l-amino acid decarboxylase (AADC) deficiency is an extremely rare, inherited neurological disorder that prevents the brain […]